| Literature DB >> 30349855 |
Sophie Adler1,2, Mallory Blackwood3, Gemma B Northam1, Roxana Gunny2, Seok-Jun Hong4, Boris C Bernhardt5, Andrea Bernasconi4, Neda Bernasconi4, Thomas Jacques6,7, Martin Tisdall1,2, David W Carmichael1,2, J Helen Cross1,2, Torsten Baldeweg1,2.
Abstract
OBJECTIVE: In contrast to adult cohorts, neocortical changes in epileptic children with hippocampal damage are not well characterized. Here, we mapped multimodal neocortical markers of epilepsy-related structural compromise in a pediatric cohort of temporal lobe epilepsy and explored how they relate to clinical factors.Entities:
Year: 2018 PMID: 30349855 PMCID: PMC6186946 DOI: 10.1002/acn3.634
Source DB: PubMed Journal: Ann Clin Transl Neurol ISSN: 2328-9503 Impact factor: 4.511
Figure 1Hippocampal atrophy and FLAIR signal intensity. Hippocampal segmentations: coronal section of T1‐weighted (A) and FLAIR (B) images; and axial (C) and sagittal (D) T1‐weighted sections in a healthy control subject. E) Reduced ipsilateral but not contralateral hippocampal volume in patients. Increased normalized FLAIR signal of ipsilateral and contralateral hippocampi in patients.
Figure 2Surface‐based processing pipeline. (A) MRI preprocessing in FreeSurfer to create pial and white matter surfaces. (B) Co‐registration of FLAIR to T1 scans. (C) Feature extraction. Quantification of cortical thickness, gray–white matter boundary intensity contrast and FLAIR signal intensity at 50% cortical depth.
Pediatric HS patient demographics
| Age | Sex | Hemi | Onset | Duration | FC | VIQ | PIQ | Blurring | Surgery | Hippocampal histology | Temporal neocortical histology | Engel Outcome | AEDs | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 12.09 | F | R | 0.5 | 11.59 | y | 81 | 86 | Y | Y | ILAE Type I HS | FCD IIIA | Ia | LVT, TPR |
| 2 | 11.38 | M | L | 2 | 9.38 | y | 53 | 55 | Y | N | TPR | |||
| 3 | 13.75 | F | L | 4 | 9.75 | n | 108 | 125 | N | Y | ILAE Type I HS | FCD IIIA | Ib | CBZ, LVT |
| 4 | 7.03 | F | L | 4.5 | 2.53 | n | 112 | 110 | N | N | LVT, VPA, OXCBZ | |||
| 5 | 11.72 | F | R | 1.5 | 10.22 | n | 83 | 90 | N | N | LVT | |||
| 6 | 11.95 | M | R | 7 | 4.95 | n | n.a. | n.a. | Y | N | None | |||
| 7 | 13.57 | F | R | 0.83 | 12.74 | y | 87 | 86 | N | N | VPA, OXCBZ | |||
| 8 | 12.01 | F | R | 1.5 | 10.51 | y | 65 | 84 | N | N | CBZ, TPR | |||
| 9 | 8.68 | F | L | 1.5 | 7.18 | y | 87 | 88 | N | Y | ILAE Type I HS | Nonspecific changes | Ia | LVT, VPA |
| 10 | 13.92 | F | R | 0.92 | 13 | y | 108 | 100 | Y | N | VPA | |||
| 11 | 10.06 | F | L | 0.25 | 9.81 | n | n.a. | n.a. | N | N | LVT, VPA | |||
| 12 | 4.71 | F | L | 1 | 3.71 | y | 93 | 79 | Y | Y | ILAE Type I HS | Nonspecific changes | IIIa | LVT, CLB, OXCBZ |
| 13 | 8.53 | M | R | 1.5 | 7.03 | y | 69 | 77 | Y | Y | ILAE Type I HS | Nonspecific changes | Ia | CBZ, LVT |
| 14 | 8.01 | F | L | 1 | 7.01 | y | 99 | 94 | Y | N | VPA, LVT | |||
| 15 | 10.21 | M | L | 3.5 | 6.71 | n | 81 | 92 | Y | Y | No diagnosis | Nonspecific changes | Ia | TPR, LVT |
| 16 | 14.87 | M | L | 9 | 5.87 | n | 105 | 109 | N | Y | Gliosis only | Reactive cavities | IIa | LTG, CLB, zonisamide, perampanel |
| 17 | 15.09 | F | L | 0.75 | 14.34 | n | 108 | 117 | N | N | OXCBZ, LVT | |||
| 18 | 4.55 | F | R | 0.75 | 3.8 | n | n.a. | n.a. | Y | Y | ILAE type II HS | Mild atrophy | Ia | VPA, LTG |
| 19 | 6.95 | M | L | 0.33 | 6.62 | n | 45 | 49 | Y | Y | ILAE Type I HS | Nonspecific changes | Ia | CBZ |
| 20 | 11.63 | M | L | 7 | 4.63 | n | 98 | 100 | N | N | VPA, TPR, LTG | |||
| 21 | 5.96 | M | L | 5 | 0.96 | n | n.a. | n.a. | N | N | Midazolam | |||
| 22 | 15.08 | M | R | 12 | 3.08 | n | n.a. | n.a. | N | N | LTG, VPA |
Age, age of patient; Hemi, affected hippocampus; Onset, age of onset of epilepsy (years); Duration, duration of epilepsy (years); FC, history of febrile convulsions; VIQ, verbal IQ; PIQ, performance IQ; Blurring, radiological report of gray–white matter blurring in the anterior temporal lobe; Hippocampal histology: ILAE classification of hippocampal sclerosis; Ia, completely seizure free; Ib, nondisabling simple partial seizures only since surgery; IIa, Initially free of disabling seizures but has rare seizures now; III, worthwhile improvement; IV, no worthwhile improvement; AEDs, anti‐epileptic drugs at time of MRI; LVT, levetiracetam; CBZ, carbamazepine; OXCBZ, oxcarbazepine; VPA, sodium valproate; CLB, clobazam; LTG, lamotrigine, TPR, topiramate; PNT, phenytoin.
No diagnosis as hippocampus not submitted.
Inconclusive due to incomplete sampling of the hippocampus. Temporal neocortical histology: histopathological changes in samples temporal lobe neocortex. Engel: postoperative surgical outcome according to Engel classification.
Group demographic data
| HS ( | CONTROLS ( |
| |
|---|---|---|---|
| AGE (mean + SD) | 10.53 ± 3.32 | 14.33 ± 3.01 | 0.001 |
| SEX (female:male) | 13:9 | 13:17 | 0.17 |
| VIQ (mean ± SD) | 89.59 ± 17.83 | 113.13 ± 14.61 | <0.001 |
| PIQ (mean ± SD) | 92.35 ± 19.57 | 115.73 ± 13.65 | <0.001 |
| ONSET (mean ± SD) | 3.02 ± 3.20 | n.a. | |
| DURATION (mean ± SD) | 7.52 ± 3.69 | n.a. | |
| HEMI (left:right) | 13:9 | n.a. | |
| SURGERY | 45.5% (10/22) | n.a. | |
| FC | 40.9% (9/22) | n.a. |
AGE, age of participants (years); VIQ, verbal IQ; PIQ, performance IQ; ONSET, age of onset of epilepsy (years); DURATION, duration of epilepsy (years); HEMI, affected hippocampus; SURGERY, patient has undergone temporal lobectomy; FC, history of febrile convulsions.
Figure 3Whole‐brain analysis. FLAIR hyperintensity (A), cortical thinning (B) and gray–white matter boundary blurring (C) in pediatric TLE patients compared to controls. Findings were corrected for multiple comparisons controlling the family‐wise error (FWE) to be below PFWE < 0.05. Difference in FLAIR hyperintensity (D), cortical thickness (E) and gray–white matter intensity contrast (F) in anterior temporal lobe cluster between TLE patients with (yes) and without (no) a history of febrile convulsions.
Figure 4Topography of neocortical FLAIR hyperintensity. Surface‐based map of the t‐statistic. Unlike Figure 3A, FLAIR hyperintensity in pediatric TLE patients compared to controls has not been corrected for multiple comparisons.